Efficacy News and Research

RSS
NEJM hails vismodegib as ‘the greatest advance in therapy yet seen’ for advanced BCC

NEJM hails vismodegib as ‘the greatest advance in therapy yet seen’ for advanced BCC

Interactive website improves parental compliance with asthma controller medication use

Interactive website improves parental compliance with asthma controller medication use

Ophthotech’s Fovista anti-PDGF combination therapy superior to Lucentis for wet AMD

Ophthotech’s Fovista anti-PDGF combination therapy superior to Lucentis for wet AMD

EnVivo to present results from EVP-6124 Phase 2b trial on AD at AAIC 2012

EnVivo to present results from EVP-6124 Phase 2b trial on AD at AAIC 2012

Enrollment complete in Endosense’s TactiCath catheter clinical study for paroxysmal AF

Enrollment complete in Endosense’s TactiCath catheter clinical study for paroxysmal AF

Investigational Insomnia Medicine from Merck improved patients’ ability to fall and stay asleep according to new phase III Data

Investigational Insomnia Medicine from Merck improved patients’ ability to fall and stay asleep according to new phase III Data

ChromaDex’s pTeroPure safe for human consumption

ChromaDex’s pTeroPure safe for human consumption

Acorda commences AMPYRA clinical study for post-stoke deficits

Acorda commences AMPYRA clinical study for post-stoke deficits

New approach can design antibiotics that kill even 'superbugs'

New approach can design antibiotics that kill even 'superbugs'

Uncertainty over efficacy of clopidogrel in hemolytic uremic syndrome

Uncertainty over efficacy of clopidogrel in hemolytic uremic syndrome

Pharmanest commences SHACT Phase II study in women

Pharmanest commences SHACT Phase II study in women

Initial trial results from KYTHERA’s second of two Phase III trials with ATX-101

Initial trial results from KYTHERA’s second of two Phase III trials with ATX-101

Genzyme files LEMTRADA sBLA and MAA with FDA, EMA for treatment of RMS

Genzyme files LEMTRADA sBLA and MAA with FDA, EMA for treatment of RMS

Investigational drug slows metastatic breast cancer progression

Investigational drug slows metastatic breast cancer progression

HackensackUMC recognizes AcquiSci d-OSAB technology with research award

HackensackUMC recognizes AcquiSci d-OSAB technology with research award

Positive results from Cara’s CR845 Phase II study on acute post-operative pain

Positive results from Cara’s CR845 Phase II study on acute post-operative pain

BioSante to initiate two new LibiGel Phase III efficacy trials in FSD, HSDD

BioSante to initiate two new LibiGel Phase III efficacy trials in FSD, HSDD

Ampio’s CRO completes Optina clinical trial for DME

Ampio’s CRO completes Optina clinical trial for DME

Nanocontainers can fight against atherosclerosis

Nanocontainers can fight against atherosclerosis

Dapagliflozin more effective than sitagliptin for adult patients with type 2 diabetes

Dapagliflozin more effective than sitagliptin for adult patients with type 2 diabetes

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.